Alzheimers Disease
Alzheimer’s Disease is a brain disorder characterized by progressive loss of memory and cognitive function, such as physical coordination and decision-making ability. Not restricted to the elderly, this disease afflicts about 18 million people worldwide—almost one-third of whom live in the United States.
Alzheimer’s disease, was first described in 1906 by german physician Alois Alzheimer. Science has advanced a great in the century since Dr. Alzheimer first drew attention to it. Today we know that Alzheimer’s:
- Is a progressive and fatal brain disease. As many as 5.3 million Americans are living with Alzheimer’s disease
- Is the most common form of dementia, a general term for the loss of memory and other intellectual abilities serious enough to interfere with daily life
- Has no current cure. Although there’s currently no cure for Alzheimer’s disease, research is under way to find a new treatment to help slow down the progression of the disease.
Northwest Clinical Research Center is actively recruiting participants for an investigational medication for the treatment of Alzheimers Disease. The aim of this study is to learn if a new medication is effective in slowing the progression of the disease.
Your loved one may qualify if he or she:
-
Is between 50 and 90 years old
-
Has a diagnosis of probable Alzheimer’s disease or has memory problems that may be a sign of Alzheimer’s Disease
-
Is not taking any medications for Alzheimer’s disease
-
Has no history of cancer within the past three years
-
Is able to attend all office visits
-
Lives with, or spends substantial periods of time with, a regular caregiver who is willing to attend all trial visits, oversee compliance, and report on the loved one’s status
If you or a family member has been diagnosed with Alzheimers or has the warning signs of Alzheimers and would like to participate in this study, please take a moment to answer the questions in the form to the right or call 877-453-0404.